Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers.

Lippa CF, Duda JE, Grossman M, Hurtig HI, Aarsland D, Boeve BF, Brooks DJ, Dickson DW, Dubois B, Emre M, Fahn S, Farmer JM, Galasko D, Galvin JE, Goetz CG, Growdon JH, Gwinn-Hardy KA, Hardy J, Heutink P, Iwatsubo T, Kosaka K, Lee VM, Leverenz JB, Masliah E, McKeith IG, Nussbaum RL, Olanow CW, Ravina BM, Singleton AB, Tanner CM, Trojanowski JQ, Wszolek ZK; DLB/PDD Working Group.

Neurology. 2007 Mar 13;68(11):812-9. Review.

PMID:
17353469
2.

Serum leptin concentrations and satiety in Parkinson's disease patients with and without weight loss.

Evidente VG, Caviness JN, Adler CH, Gwinn-Hardy KA, Pratley RE.

Mov Disord. 2001 Sep;16(5):924-7.

PMID:
11746624
3.

Persistent chorea triggered by hyperglycemic crisis in diabetics.

Ahlskog JE, Nishino H, Evidente VG, Tulloch JW, Forbes GS, Caviness JN, Gwinn-Hardy KA.

Mov Disord. 2001 Sep;16(5):890-8.

PMID:
11746619
4.

Hereditary ataxias.

Evidente VG, Gwinn-Hardy KA, Caviness JN, Gilman S.

Mayo Clin Proc. 2000 May;75(5):475-90. Review.

PMID:
10807077
5.

Effect of hormone variations and other factors on symptom severity in women with dystonia.

Gwinn-Hardy KA, Adler CH, Weaver AL, Fish NM, Newman SJ.

Mayo Clin Proc. 2000 Mar;75(3):235-40.

PMID:
10725948
6.

A kindred with Parkinson's disease not showing genetic linkage to established loci.

Gwinn-Hardy KA, Crook R, Lincoln S, Adler CH, Caviness JN, Hardy J, Farrer M.

Neurology. 2000 Jan 25;54(2):504-7.

PMID:
10668726

Supplemental Content

Loading ...
Support Center